Tang, A. S. P., Hsu, J. T. Y., Chong, S. K. S., Quek, J., Shek, G., Sulaimi, F., Chan, K. E., Anand, V. V., Chong, B., Mehta, A., Toh, S.-A., Muthiah, M., Dimitriadis, G. K., le Roux, C. W., Chan, M. Y.-Y., Mamas, M. A., Chin, Y. H., & Chew, N. W. S. (2025). Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety. Cardiovascular diabetology, 24(1), 285. https://doi.org/10.1186/s12933-025-02840-3